Literature DB >> 3871426

Cellular and humoral immune responses of mice subclinically infected with Pneumocystis carinii.

T Furuta, K Ueda, K Fujiwara, K Yamanouchi.   

Abstract

Cellular and humoral immune responses to Pneumocystis carinii were investigated. ICR and DDD mice were intranasally infected with 10(4) mouse lung-derived P. carinii, and the delayed-type hypersensitivity (DTH) reaction and antibody titers to P. carinii were measured along with the number of P. carinii cysts in the lungs after infection. The number of P. carinii cysts in the lungs peaked at 2 weeks after infection and then decreased to barely detectable levels by 4 weeks. Serum antibody (immunoglobulin G) titers measured by indirect immunofluorescence increased up to 4 weeks. The DTH footpad reaction was most prominent at 2 weeks postinfection and declined thereafter. Thus, the decline in the number of P. carinii cysts in the lungs corresponded well with the time of the peak of the DTH reaction but not with the serum antibody response. Spleen T cells from infected mice mediated the DTH reaction when transferred intravenously into normal recipients and reduced the number of P. carinii cysts in the lungs when transferred intravenously into P. carinii-infected mice. The results indicated that cellular immunity is important for protection from subclinical P. carinii infections.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871426      PMCID: PMC263206          DOI: 10.1128/iai.47.2.544-548.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  A NEW PROCEDURE FOR THE IDENTIFICATION OF PNEUMOCYSTIS CARINII CYSTS IN TISSUE SECTIONS AND SMEARS.

Authors:  A M CHALVARDJIAN; L A GRAWE
Journal:  J Clin Pathol       Date:  1963-07       Impact factor: 3.411

2.  Latent Pneumocystis infection of rats, relapse, and chemotherapy.

Authors:  J K Frenkel; J T Good; J A Shultz
Journal:  Lab Invest       Date:  1966-10       Impact factor: 5.662

3.  Nude mouse: a new experimental model for Pneumocystis carinii infection.

Authors:  P D Walzer; V Schnelle; D Armstrong; P P Rosen
Journal:  Science       Date:  1977-07-08       Impact factor: 47.728

4.  Chronic fatal pneumocystosis in nude mice.

Authors:  K Ueda; Y Goto; S Yamazaki; K Fujiwara
Journal:  Jpn J Exp Med       Date:  1977-12

5.  Serum antibody responses to Pneumocystis carinii among different strains of normal and athymic mice.

Authors:  P D Walzer; M E Rutledge
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

6.  The in vitro response of human lymphocytes to Pneumocystis carinii antigen.

Authors:  H G Herrod; W R Valenski; D R Woods; L L Pifer
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

7.  Experimental Pneumocystis carinii infection in nude rats.

Authors:  T Furuta; K Ueda; K Fujiwara
Journal:  Jpn J Exp Med       Date:  1984-04

8.  Effect of T-cell transfer on Pneumocystis carinii infection in nude mice.

Authors:  T Furuta; K Ueda; S Kyuwa; K Fujiwara
Journal:  Jpn J Exp Med       Date:  1984-04

9.  Humoral immunity in experimental Pneumocystis carinii infection. I. Serum and bronchial lavage fluid antibody responses in rats.

Authors:  P D Walzer; M E Rutledge
Journal:  J Lab Clin Med       Date:  1981-06

10.  The interaction in vitro of Pneumocystis carinii with macrophages and L-cells.

Authors:  H Masur; T C Jones
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

  10 in total
  16 in total

Review 1.  Pneumocystis carinii, an opportunist in immunocompromised patients.

Authors:  M S Bartlett; J W Smith
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

2.  Pneumocystis carinii infection causes lung lesions historically attributed to rat respiratory virus.

Authors:  Robert S Livingston; Cynthia L Besch-Williford; Matthew H Myles; Craig L Franklin; Marcus J Crim; Lela K Riley
Journal:  Comp Med       Date:  2011-02       Impact factor: 0.982

Review 3.  Prevention of infection due to Pneumocystis carinii.

Authors:  J A Fishman
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

4.  HIV in the lung: guilty or not guilty?

Authors:  C M Mayaud; J Cadranel
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

5.  New rat model of Pneumocystis carinii infection.

Authors:  M S Bartlett; J A Fishman; S F Queener; M M Durkin; M A Jay; J W Smith
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

6.  Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.

Authors:  C J Boylan; W L Current
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice.

Authors:  J B Roths; C L Sidman
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

8.  Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice.

Authors:  J B Roths; C L Sidman
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Use of anti-CD4+ hybridoma cells to induce Pneumocystis carinii in mice.

Authors:  D C McFadden; M A Powles; J G Smith; A M Flattery; K Bartizal; D M Schmatz
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

10.  Serological observations of Pneumocystis carinii infection in humans.

Authors:  K Tanabe; T Furuta; K Ueda; H Tanaka; K Shimada
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.